Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 27
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Sensors (Basel) ; 23(3)2023 Jan 23.
Artigo em Inglês | MEDLINE | ID: mdl-36772335

RESUMO

The modelling of IoT applications utilising the resources of cloud and fog computing is not straightforward because they have to support various trigger-based events that make human life easier. The sequence of tasks, such as performing a service call, receiving a data packet in the form of a message sent by an IoT device, and managing actuators or executing a computational task on a virtual machine, are often associated with and composed of IoT workflows. The development and deployment of such IoT workflows and their management systems in real life, including communication and network operations, can be complicated due to high operation costs and access limitations. Therefore, simulation solutions are often applied for such purposes. In this paper, we introduce a novel simulator extension of the DISSECT-CF-Fog simulator that leverages the workflow scheduling and its execution capabilities to model real-life IoT use cases. We also show that state-of-the-art simulators typically omit the IoT factor in the case of the scientific workflow evaluation. Therefore, we present a scalability study focusing on scientific workflows and on the interoperability of scientific and IoT workflows in DISSECT-CF-Fog.

2.
Sensors (Basel) ; 21(17)2021 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-34502784

RESUMO

The recent development in wireless networks and devices leads to novel services that will utilize wireless communication on a new level [...].


Assuntos
Tecnologia , Tecnologia sem Fio , Comunicação
3.
Sensors (Basel) ; 20(7)2020 Mar 29.
Artigo em Inglês | MEDLINE | ID: mdl-32235361

RESUMO

In the scope of evaluation methodologies for Internet of Things (IoT) systems, some approaches concern security, while others latency. However, some methodologies evaluate systems that contain active entities, so-called actuators. In this paper, we propose a novel methodology for evaluating such systems with actuator components using Graph Representation of the Angle of the Force and Time (GRAFT). GRAFT facilitates easy computation of the net force produced by physical or mechanical acts occurring on a daily basis on Earth. We use laws and definitions of physics describing the relations between Speed, Distance, and Time (SDT), apply them in a heliocentric system, and model the considered systems with a graph. The continuous movement of the Earth was shown to be weakening the total produced net force in some systems. We considered this weakening issue a problem, and we propose two possible solutions to overcome it by using restoration values, or reordering actuator sessions, in GRAFT to arrive to a more force-efficient system. We compared our default GRAFT algorithm to a special implementation using the Clock-Angle-Problem (CAP) for sessions. We also study and discuss an IoT-focused case for validating our approach, and we present a detailed explanation of the proposed GRAFT algorithm. The experimental results show the ability of GRAFT to provide highly accurate results, which also exemplifies that our GRAFT approach is programmable, hence deployable in real life scenarios.

4.
J Transl Med ; 17(1): 229, 2019 07 19.
Artigo em Inglês | MEDLINE | ID: mdl-31324258

RESUMO

BACKGROUND: Chemotherapy-induced left ventricular dysfunction represents a major clinical problem, which is often only recognised at an advanced stage, when supportive therapy is ineffective. Although an early heart failure treatment could positively influence the health status and clinical outcome, there is still no evidence of routine prophylactic cardioprotection for the majority of patients without previous cardiovascular history awaiting potentially cardiotoxic chemotherapy. In this study, we set out to investigate whether a prophylactic cardioprotective therapy relative to a conventionally scheduled heart failure treatment is more effective in preventing cardiotoxicity in a rodent model of doxorubicin (DOX)-induced cardiomyopathy. METHODS: Male Wistar rats (n = 7-11 per group) were divided into 4 subgroups, namely negative controls receiving intravenous saline (CON), positive controls receiving intravenous DOX (6 cycles; D-CON), and DOX-treated animals receiving either prophylactic (PRE, started 1 week before DOX) or conventionally applied (POST, started 1 month after DOX) combined heart failure therapy of oral bisoprolol, perindopril and eplerenone. Blood pressure, heart rate, body weight and echocardiographic parameters were monitored in vivo, whereas myocardial fibrosis, capillarisation, ultrastructure, myofilament function, apoptosis, oxidative stress and mitochondrial biogenesis were studied in vitro. RESULTS: The survival rate in the PRE group was significantly improved compared to D-CON (p = 0.0207). DOX increased the heart rate of the animals (p = 0.0193), while the blood pressure (p ≤ 0.0105) and heart rate (p = 0.0029) were significantly reduced in the PRE group compared to D-CON and POST. The ejection fraction remained preserved in the PRE group compared to D-CON or POST (p ≤ 0.0237), while none of the treatments could prevent the DOX-induced increase in the isovolumetric relaxation time. DOX decreased the rate of the actin-myosin cross-bridge cycle, irrespective of any treatment applied (p ≤ 0.0433). The myocardium of the D-CON and POST animals displayed pronounced ultrastructural damage, which was not apparent in the PRE group (p ≤ 0.033). While the DOX-induced apoptotic activity could be reduced in both the PRE and POST groups (p ≤ 0.0433), no treatment was able to prevent fibrotic remodelling or the disturbed mitochondrial biogenesis. CONCLUSION: For attenuating DOX-induced adverse myocardial effects, prophylactic cardioprotection has many advantages compared to a late-applied treatment.


Assuntos
Cardiomiopatias/induzido quimicamente , Cardiomiopatias/terapia , Doxorrubicina/efeitos adversos , Insuficiência Cardíaca/terapia , Animais , Apoptose , Cardiomiopatias/diagnóstico por imagem , Caspase 3/metabolismo , Modelos Animais de Doenças , Ecocardiografia , Fibrose , Insuficiência Cardíaca/diagnóstico por imagem , Masculino , Miocárdio/patologia , Miocárdio/ultraestrutura , Miócitos Cardíacos/metabolismo , Miócitos Cardíacos/patologia , Ratos Wistar , Análise de Sobrevida
5.
Orv Hetil ; 159(13): 526-530, 2018 Apr.
Artigo em Húngaro | MEDLINE | ID: mdl-29577764

RESUMO

Dilated cardiomyopathy is the main cause of heart transplantation. The etiology is unknown in almost half of the cases. Many cardiac specific antibodies have been identified till now which can cause decreased cardiac function, ventricular tachycardia or sudden heart death. The prognosis of DCM is poor despite the development of medical treatment. Immunoadsorption is hopeful since, with the removal of antibodies, cardiac function and NYHA class can improve and LVAD/heart transplantation-free survival can be prolonged. At the University of Debrecen, Faculty of Medicine, Department of Internal Medicine, Division of Angiology, Intensive Care and Therapeutic Apheresis Unit we performed the first immunoadsorption. Our patient was a 43-year-old man with idiopathic dilated cardiomyopathy, NYHA class IV, a heart transplantation candidate, whose cardiac specific antibody, type IgG was indentified by Western blot. Before the treatment he had ejection fraction of 18%. Discussing with his cardiologists we decided for immunoadsorption therapy. We performed 5 cycles on consecutive days in Intensive Care Unit. After 1 month we detected improvement in exercise capacity. We detected improvement in isovolemic contraction (from 465 mmHg/s to 575 mmHg/s), increased stroke volume (from 49 ml to 66 ml). After 3 months we repeated SPECT investigation which showed improvement in ejection fraction, from 18% to 32%. Orv Hetil. 2018; 159(13): 532-536.


Assuntos
Cardiomiopatia Dilatada/terapia , Técnicas de Imunoadsorção , Adulto , Cardiomiopatia Dilatada/sangue , Humanos , Hungria , Imunoglobulina G/sangue , Masculino , Volume Sistólico , Resultado do Tratamento
6.
Int J Mol Sci ; 18(7)2017 Jul 04.
Artigo em Inglês | MEDLINE | ID: mdl-28677661

RESUMO

Right-sided heart failure-often caused by elevated pulmonary arterial pressure-is a chronic and progressive condition with particularly high mortality rates. Recent studies and our current findings suggest that components of Wild garlic (Allium ursinum, AU) may play a role in reducing blood pressure, inhibiting angiotensin-converting enzyme (ACE), as well as improving right ventricle function in rabbit models with heart failure. We hypothesize that AU may mitigate cardiovascular damage caused by pulmonary arterial hypertension (PAH) and has value in the supplementary treatment of the complications of the disease. In this present investigation, PAH was induced by a single dose of monocrotaline (MCT) injection in Sprague-Dawley rats, and animals were divided into 4 treatment groups as follows: I. healthy control animals (Control group); II. pulmonary hypertensive rats (PAH group); III. pulmonary hypertensive rats + daily sildenafil treatment (Sildenafil group); and IV. pulmonary hypertensive rats + Wild garlic liophylisate-enriched chow (WGLL group), for 8 weeks. Echocardiographic measurements were obtained on the 0 and 8 weeks with fundamental and Doppler imaging. Isolated working heart method was used to determinate cardiac functions ex vivo after thoracotomy on the 8th week. Histological analyses were carried out on excised lung samples, and Western blot technique was used to determine Phosphodiesterase type 5 enzyme (PDE5) expression in both myocardial and pulmonary tissues. Our data demonstrate that right ventricle function measured by echocardiography was deteriorated in PAH animals compared to controls, which was counteracted by AU treatment. Isolated working heart measurements showed elevated aortic flow in WGLL group compared to PAH animals. Histological analysis revealed dramatic increase in medial wall thickness of pulmonary arteries harvested from PAH animals, but arteries of animals in sildenafil- and WGLL-treated groups showed physiological status. Our results suggest that bioactive compounds in Allium ursinum could have beneficial effects in pulmonary hypertension.


Assuntos
Allium/química , Hipertensão Pulmonar/fisiopatologia , Extratos Vegetais/farmacologia , Artéria Pulmonar/efeitos dos fármacos , Artéria Pulmonar/fisiopatologia , Animais , Biomarcadores , Modelos Animais de Doenças , Ecocardiografia , Testes de Função Cardíaca , Hipertensão Pulmonar/diagnóstico , Hipertensão Pulmonar/tratamento farmacológico , Hipertensão Pulmonar/metabolismo , Pulmão/metabolismo , Pulmão/patologia , Masculino , Espectrometria de Massas , Miocárdio/metabolismo , Miocárdio/patologia , Extratos Vegetais/química , Artéria Pulmonar/metabolismo , Ratos , Citrato de Sildenafila/farmacologia
7.
Arch Virol ; 161(4): 1033-7, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-26733298

RESUMO

In this study, a novel parvovirus (strain swine/Zsana3/2013/HUN, KT965075) was detected in domestic pigs and genetically characterized by viral metagenomics and PCR methods. The novel parvovirus was distantly related to the human bufaviruses and was detected in 19 (90.5 %) of the 21 and five (33.3 %) of the 15 faecal samples collected from animals with and without cases of posterior paraplegia of unknown etiology from five affected farms and one control farm in Hungary, respectively. Swine/Zsana3/2013/HUN is highly prevalent in domestic pigs and potentially represents a novel parvovirus species in the subfamily Parvovirinae.


Assuntos
Infecções por Parvoviridae/veterinária , Parvovirus/genética , Parvovirus/isolamento & purificação , Doenças dos Suínos/virologia , Envelhecimento , Animais , Fezes/virologia , Feminino , Humanos , Hungria/epidemiologia , Infecções por Parvoviridae/epidemiologia , Infecções por Parvoviridae/virologia , Filogenia , Suínos , Doenças dos Suínos/epidemiologia
8.
Int J Mol Sci ; 17(8)2016 Aug 10.
Artigo em Inglês | MEDLINE | ID: mdl-27517918

RESUMO

The present investigation evaluates the capacity of Allium ursinum (wild garlic) leaf lyophilisate (WGLL; alliin content: 0.261%) to mitigate cardiovascular damage in hypercholesterolemic rabbits. New Zealand rabbits were divided into three groups: (i) cholesterol-free rabbit chow (control); (ii) rabbit chow containing 2% cholesterol (hypercholesterolemic, HC); (iii) rabbit chow containing 2% cholesterol + 2% WGLL (hypercholesterolemic treated, HCT); for eight weeks. At the zero- and eight-week time points, echocardiographic measurements were made, along with the determination of basic serum parameters. Following the treatment period, after ischemia-reperfusion injury, hemodynamic parameters were measured using an isolated working heart model. Western blot analyses of heart tissue followed for evaluating protein expression and histochemical study for the atheroma status determination. WGLL treatment mediated increases in fractional shortening; right ventricular function; peak systolic velocity; tricuspidal annular systolic velocity in live animals; along with improved aortic and coronary flow. Western blot analysis revealed WGLL-associated increases in HO-1 protein and decreases in SOD-1 protein production. WGLL-associated decreases were observed in aortic atherosclerotic plaque coverage, plasma ApoB and the activity of LDH and CK (creatine kinase) in plasma. Plasma LDL was also significantly reduced. The results clearly demonstrate that WGLL has complex cardioprotective effects, suggesting future strategies for its use in prevention and therapy for atherosclerotic disorders.


Assuntos
Allium/química , Aterosclerose/metabolismo , Biomarcadores/metabolismo , Hipercolesterolemia/tratamento farmacológico , Hipercolesterolemia/metabolismo , Lipoproteínas/metabolismo , Extratos Vegetais/uso terapêutico , Animais , Aterosclerose/tratamento farmacológico , Ecocardiografia , Masculino , Coelhos
9.
Orv Hetil ; 156(22): 896-900, 2015 May 31.
Artigo em Húngaro | MEDLINE | ID: mdl-26004549

RESUMO

The incidence of infective endocarditis is underestimated in solid organ transplant recipients. The spectrum of pathogens is different from the general population. The authors report the successful treatment of a 58-year-old woman with infective endocarditis caused by atypical microorganism and presented with atypical manifestations. Past history of the patient included alcoholic liver cirrhosis and cadaver liver transplantation in February 2000. One year after liver transplantation hepatitis B virus infection was diagnosed and treated with antiviral agents. In July 2007 hemodialysis was started due to progressive chronic kidney disease caused by calcineurin toxicity. In November 2013 the patient presented with transient aphasia. Transesophageal echocardiography revealed vegetation in the aortic valve and brain embolization was identified on magnetic resonance images. Initial treatment consisted of a 4-week regimen with ceftriaxone (2 g daily) and gentamycin (60 mg after hemodialysis). Blood cultures were all negative while serology revealed high titre of antibodies against Chlamydia pneumoniae. Moxifloxacin was added as an anti-chlamydial agent, but neurologic symptoms returned. After coronarography, valvular surgery and coronary artery bypass surgery were performed which resulted in full clinical recovery of the patient.


Assuntos
Antibacterianos/uso terapêutico , Valva Aórtica/microbiologia , Chlamydia/isolamento & purificação , Endocardite Bacteriana/etiologia , Implante de Prótese de Valva Cardíaca , Embolia Intracraniana/microbiologia , Transplante de Fígado , Diálise Renal , Antibacterianos/administração & dosagem , Anticorpos Antibacterianos/sangue , Valva Aórtica/cirurgia , Afasia/etiologia , Encéfalo/microbiologia , Encéfalo/patologia , Calcineurina/toxicidade , Ceftriaxona/administração & dosagem , Chlamydia/imunologia , Ponte de Artéria Coronária , Esquema de Medicação , Ecocardiografia Transesofagiana , Endocardite Bacteriana/diagnóstico por imagem , Endocardite Bacteriana/microbiologia , Feminino , Fluoroquinolonas/administração & dosagem , Gentamicinas/administração & dosagem , Humanos , Embolia Intracraniana/complicações , Embolia Intracraniana/diagnóstico , Transplante de Fígado/efeitos adversos , Imageamento por Ressonância Magnética , Pessoa de Meia-Idade , Moxifloxacina , Diálise Renal/efeitos adversos , Insuficiência Renal Crônica/etiologia , Insuficiência Renal Crônica/terapia , Resultado do Tratamento
10.
BMC Nephrol ; 14: 76, 2013 Apr 02.
Artigo em Inglês | MEDLINE | ID: mdl-23547981

RESUMO

BACKGROUND: Renal replacement therapy may have a favorable effect on diastolic left ventricular function, but it is not clear whether hemodiafiltration is superior to hemodialysis in this field. Nitric oxide (NO) and asymmetric dimethylarginine (ADMA) may play a role in the changes of intracardiac hemodynamics, but it is not clear whether the different renal replacement methods have disparate influence on the metabolism of these materials. METHODS: Thirty patients on renal replacement therapy were investigated. First, data was analyzed while patients received hemodiafiltration over a period of three months. Then, the same patients were evaluated during treatment with hemodialysis for at least another three months. Echocardiography was performed before and after renal replacement therapy. RESULTS: No significant difference was found in the volume removals between hemodialysis and hemodiafiltration. The left atrial diameter and transmitral flow velocities (E/A) decreased significantly only during hemodiafiltration. A positive correlation was observed between the left atrial diameter and E/Ea representing the left ventricular pressure load during hemodiafiltration. Significant correlations between NO and A and E/A were observed only in the case of hemodiafiltration. CONCLUSION: Hemodiafiltration has a beneficial effect on echocardiographic markers representing left ventricular diastolic function. This could be attributed to the differences between the dynamics of volume removal and its distribution among liquid compartments.


Assuntos
Ventrículos do Coração/diagnóstico por imagem , Ventrículos do Coração/metabolismo , Hemodiafiltração/métodos , Função Ventricular Esquerda/fisiologia , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Óxido Nítrico/sangue , Diálise Renal/métodos , Ultrassonografia
11.
Int J Mol Sci ; 14(9): 19086-108, 2013 Sep 17.
Artigo em Inglês | MEDLINE | ID: mdl-24048247

RESUMO

The present study evaluates a hypothesis that diet-related hypercholesterolemia increases oxidative stress-related burden to cardiovascular tissue, resulting in progressively increased mortality, along with deterioration of electrophysiological and enzymatic function in rabbit myocardium. New Zealand white rabbits were divided into four groups, defined as follows: GROUP I, cholesterol-free rabbit chow for 12 weeks; GROUP II, cholesterol-free chow, 40 weeks; GROUP III, chow supplemented with 2% cholesterol, 12 weeks; GROUP IV, chow supplemented with 2% cholesterol, 40 weeks. At the 12 and 40 weeks time points, animals in each of the aforementioned cohorts were subjected to echocardiographic measurements, followed by sacrifice. Significant deterioration in major outcome variables measured in the present study were observed only in animals maintained for 40 weeks on 2% cholesterol-supplemented chow, with much lesser adverse effects noted in animals fed high cholesterol diets for only 12 weeks. It was observed that rabbits receiving high cholesterol diets for 40 weeks exhibited significantly increased mortality, worsened ejection fraction and general deterioration of cardiac functions, along with increased atherosclerotic plaque formation and infarct size. Additionally, myocardium of GROUP IV animals was observed to contain lower levels of heme oxygenase-1 (HO-1) and cytochrome c oxidase III (COX III) protein relative to the controls.


Assuntos
Dieta Hiperlipídica , Hipercolesterolemia/etiologia , Miocárdio/metabolismo , Animais , Colesterol/sangue , Ecocardiografia , Complexo IV da Cadeia de Transporte de Elétrons/metabolismo , Heme Oxigenase-1/metabolismo , Hipercolesterolemia/mortalidade , Masculino , Miocárdio/enzimologia , Placa Aterosclerótica , Coelhos
12.
Antioxidants (Basel) ; 12(9)2023 Sep 04.
Artigo em Inglês | MEDLINE | ID: mdl-37760021

RESUMO

The extracts of whole plants or specific organs from different plant species are gaining increasing attention for their phytotherapy applications. Accordingly, we prepared standardized gemmotherapy extracts (GTEs) from young shoots/buds of olive (Olea europaea), sweet almond (Prunus amygdalus), and black mulberry (Morus nigra), and analyzed the corresponding phytonutrient profiles. We identified 42, 103, and 109 phytonutrients in the olive, almond, and black mulberry GTEs, respectively, containing amino acids, vitamins, polyphenols, flavonoids, coumarins, alkaloids, iridoids, carboxylic acids, lignans, terpenoids, and others. In order to assess the physiological effects generated by the GTEs, we developed a translational nutrition model based on Drosophila melanogaster and Cyprinus carpio. The results indicate that GTEs could influence, to a variable extent, viability and ATP synthesis, even though both are dependent on the specific carbohydrate load of the applied diet and the amino acid and polyphenol pools provided by the GTEs. It seems, therefore, likely that the complex chemical composition of the GTEs offers nutritional properties that cannot be separated from the health-promoting mechanisms that ultimately increase viability and survival. Such an approach sets the paves the way for the nutritional genomic descriptions regarding GTE-associated health-promoting effects.

13.
Int J Cardiol ; 376: 35-45, 2023 04 01.
Artigo em Inglês | MEDLINE | ID: mdl-36657566

RESUMO

BACKGROUND: Transcatheter aortic and mitral valve-in-valve (ViV) or valve-in-ring (ViR) implantation into failed bioprosthetic heart valves (BHVs) or rings represents an appealing, less invasive, treatment option for patients at high surgical risk. Nowadays, few data have been reported on the use of balloon-expandable Myval (Meril Life Science, Vapi, India) transcatheter heart valve (THV) for the treatment of degenerated BHVs or rings. We aimed at evaluating the early and mid-term clinical outcomes of patients with left side heart bioprosthesis deterioration treated with transcatheter ViV/ViR implantation using Myval THV. METHODS: 97 consecutive patients with symptomatic, severe aortic(n=33) and mitral(n=64) BHVs/ring dysfunction underwent transcatheter aortic ViV and mitral ViV/ViR implantation with Myval THV. RESULTS: Technical success was achieved in 95 (98%) of the patients. Two cases of acute structural trans-catheter mitral ViV/ViR dysfunction requiring a second THV implantation were reported. At 30-day, a significant reduction in prosthetic trans-valvular pressure gradients and increase in valve areas were seen following both aortic and mitral ViV/ViR implantation. Overall survival at 15 months (IQR 8-21) was 92%. Patients undergoing mitral ViV/ViR had a relatively worse survival compared with those undergoing aortic ViV implantation (89% vs. 97% respectively; HR:2.7,CI:0.33-22.7;p=0.34). At longest follow-up available a significant improvement in NYHA functional class I and II was observed in patients with aortic and mitral ViV/ViR implantation(93.8% and 92.1%). CONCLUSIONS: Despite high surgical risk, transcatheter ViV/ViR implantation for failed left side heart bioprosthesis can be performed safely using Myval THV with a high success rate and low early and mid-term mortality and morbidity.


Assuntos
Bioprótese , Implante de Prótese de Valva Cardíaca , Próteses Valvulares Cardíacas , Substituição da Valva Aórtica Transcateter , Humanos , Implante de Prótese de Valva Cardíaca/efeitos adversos , Próteses Valvulares Cardíacas/efeitos adversos , Seguimentos , Falha de Prótese , Resultado do Tratamento , Valva Mitral/cirurgia , Valva Aórtica/cirurgia , Catéteres , Bioprótese/efeitos adversos , Desenho de Prótese
14.
Mol Cell Biochem ; 348(1-2): 199-203, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-21052791

RESUMO

The present study examined the efficacy of using longevinex, a commercially available resveratrol formulation, to lower blood cholesterol in hypercholesteromic rabbits. New Zealand white rabbits were randomly divided into two groups (n = 6 per group), one group was given high cholesterol diet for 3 months while the other group fed regular diet served as control. The high cholesterol diet fed group was further subdivided into two groups (n = 6 per group), one group was given longevinex resveratrol while the other group given vehicle only served as control. Longevinex was given by gavaging up to a period of 6 months. Longevinex-treated rabbits exhibited lowering of plasma cholesterol level. Inhibition of arterial plaque formation was noticed even after 1 month. Longevinex-treated hearts demonstrated improved ventricular recovery when isolated working hearts were subjected to 30 min of ischemia followed by 2 h of reperfusion. Aortic flow and developed pressure during post-ischemic reperfusion period were significantly higher for the longevinex-treated hearts compared to those in control group of hearts. Myocardial infarct size was also lower in the treated group compared to that for the untreated group. These results indicate cholesterol-lowering ability of longevinex, which appears to reflect in its ability to protect the hypercholesteromic hearts from ischemic reperfusion injury.


Assuntos
Anticolesterolemiantes/farmacologia , Arteriosclerose/prevenção & controle , Colesterol/sangue , Hipercolesterolemia/tratamento farmacológico , Infarto do Miocárdio/prevenção & controle , Isquemia Miocárdica/tratamento farmacológico , Traumatismo por Reperfusão Miocárdica/prevenção & controle , Estilbenos/farmacologia , Animais , Arteriosclerose/etiologia , Arteriosclerose/patologia , Arteriosclerose/fisiopatologia , Biomarcadores/sangue , Modelos Animais de Doenças , Regulação para Baixo , Hemodinâmica/efeitos dos fármacos , Hipercolesterolemia/sangue , Hipercolesterolemia/complicações , Masculino , Infarto do Miocárdio/etiologia , Infarto do Miocárdio/patologia , Infarto do Miocárdio/fisiopatologia , Isquemia Miocárdica/etiologia , Isquemia Miocárdica/patologia , Isquemia Miocárdica/fisiopatologia , Traumatismo por Reperfusão Miocárdica/etiologia , Traumatismo por Reperfusão Miocárdica/patologia , Traumatismo por Reperfusão Miocárdica/fisiopatologia , Miocárdio/patologia , Coelhos , Resveratrol , Fatores de Tempo , Função Ventricular Esquerda/efeitos dos fármacos , Pressão Ventricular/efeitos dos fármacos
15.
PeerJ Comput Sci ; 7: e431, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-33977127

RESUMO

A lot of hard work and years of research are still needed for developing successful Blockchain (BC) applications. Although it is not yet standardized, BC technology was proven as to be an enhancement factor for security, decentralization, and reliability, leading to be successfully implemented in cryptocurrency industries. Fog computing (FC) is one of the recently emerged paradigms that needs to be improved to serve Internet of Things (IoT) environments of the future. As hundreds of projects, ideas, and systems were proposed, one can find a great R&D potential for integrating BC and FC technologies. Examples of organizations contributing to the R&D of these two technologies, and their integration, include Linux, IBM, Google, Microsoft, and others. To validate an integrated Fog-Blockchain protocol or method implementation, before the deployment phase, a suitable and accurate simulation environment is needed. Such validation should save a great deal of costs and efforts on researchers and companies adopting this integration. Current available simulation environments facilitate Fog simulation, or BC simulation, but not both. In this paper, we introduce a Fog-Blockchain simulator, namely FoBSim, with the main goal to ease the experimentation and validation of integrated Fog-Blockchain approaches. According to our proposed workflow of simulation, we implement different Consensus Algorithms (CA), different deployment options of the BC in the FC architecture, and different functionalities of the BC in the simulation. Furthermore, technical details and algorithms on the simulated integration are provided. We validate FoBSim by describing the technologies used within FoBSim, highlighting FoBSim's novelty compared to the state-of-the-art, discussing the event validity in FoBSim, and providing a clear walk-through validation. Finally, we simulate case studies, then present and analyze the obtained results, where deploying the BC network in the fog layer shows enhanced efficiency in terms of total run time and total storage cost.

16.
PeerJ Comput Sci ; 7: e478, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34013027

RESUMO

Global average temperature had been significantly increasing during the past century, mainly due to the growing rates of greenhouse gas (GHG) emissions, leading to a global warming problem. Many research works indicated other causes of this problem, such as the anthropogenic heat flux (AHF). Cloud computing (CC) data centers (DCs), for example, perform massive computational tasks for end users, leading to emit huge amounts of waste heat towards the surrounding (local) atmosphere in the form of AHF. Out of the total power consumption of a public cloud DC, nearly 10% is wasted in the form of heat. In this paper, we quantitatively and qualitatively analyze the current state of AHF emissions of the top three cloud service providers (i.e., Google, Azure and Amazon) according to their average energy consumption and the global distribution of their DCs. In this study, we found that Microsoft Azure DCs emit the highest amounts of AHF, followed by Amazon and Google, respectively. We also found that Europe is the most negatively affected by AHF of public DCs, due to its small area relative to other continents and the large number of cloud DCs within. Accordingly, we present mean estimations of continental AHF density per square meter. Following our results, we found that the top three clouds (with waste heat at a rate of 1,720.512 MW) contribute an average of more than 2.8% out of averaged continental AHF emissions. Using this percentage, we provide future trends estimations of AHF densities in the period [2020-2100]. In one of the presented scenarios, our estimations predict that by 2100, AHF of public clouds DCs will reach 0.01 Wm-2.

17.
PeerJ Comput Sci ; 7: e651, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34401476

RESUMO

The inevitable evolution of information technology has led to the creation of IoT-Fog-Cloud systems, which combine the Internet of Things (IoT), Cloud Computing and Fog Computing. IoT systems are composed of possibly up to billions of smart devices, sensors and actuators connected through the Internet, and these components continuously generate large amounts of data. Cloud and fog services assist the data processing and storage needs of IoT devices. The behaviour of these devices can change dynamically (e.g. properties of data generation or device states). We refer to systems allowing behavioural changes in physical position (i.e. geolocation), as the Internet of Mobile Things (IoMT). The investigation and detailed analysis of such complex systems can be fostered by simulation solutions. The currently available, related simulation tools are lacking a generic actuator model including mobility management. In this paper, we present an extension of the DISSECT-CF-Fog simulator to support the analysis of arbitrary actuator events and mobility capabilities of IoT devices in IoT-Fog-Cloud systems. The main contributions of our work are: (i) a generic actuator model and its implementation in DISSECT-CF-Fog, and (ii) the evaluation of its use through logistics and healthcare scenarios. Our results show that we can successfully model IoMT systems and behavioural changes of actuators in IoT-Fog-Cloud systems in general, and analyse their management issues in terms of usage cost and execution time.

18.
Geroscience ; 43(1): 19-29, 2021 02.
Artigo em Inglês | MEDLINE | ID: mdl-33469835

RESUMO

Coronavirus disease 2019 (COVID-19) has a high mortality in elderly patients with pre-existing cardiovascular diseases. The cellular receptor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the angiotensin-converting enzyme 2 (ACE2), thereby implicating a link between cardiovascular diseases and SARS-CoV-2 susceptibility. Aortic stenosis (AS) represents a chronic inflammatory state with severe cardiovascular complications in the elderly, a prime condition for COVID-19 mortality. The circulating ACE2 levels were measured in 111 patients with severe AS and compared to patients with hypertension and healthy individuals. About 4 times higher circulating ACE2 activity was found in patients with severe AS than in hypertensives or healthy individuals (88.3 ± 61.6., n = 111, 20.6 ± 13.4, n = 540, and 16.1 ± 7.4 mU/L, n = 46, respectively). Patients with severe AS were older than patients with hypertension (80 ± 6 years vs. 60 ± 15 years, P < 0.05). Serum ACE2 activity correlated negatively with the left ventricular ejection fraction, aortic root area, TAPSE, and positively with the right ventricular systolic pressure, cardiac diameters in patients with AS. In contrast, circulating ACE2 activity was independent of the blood pressure, peak flow velocity at the aortic root, kidney function (GFR), and inflammatory state (CRP). We found no effect of RAAS inhibitory drugs on the serum ACE2 activity in this group of patients. Our results illustrate circulating ACE2 as a potential interface between chronic inflammation, cardiovascular disease, and COVID-19 susceptibility. Elderly patients with AS have markedly elevated ACE2 levels together with altered left and right ventricular functions, which may pose higher risks during COVID-19. Our clinical data do not support a role for RAAS inhibitors in regulating circulating ACE2 levels.


Assuntos
Estenose da Valva Aórtica , COVID-19 , Idoso , Enzima de Conversão de Angiotensina 2 , Biomarcadores , Humanos , Pessoa de Meia-Idade , Peptidil Dipeptidase A , Sistema Renina-Angiotensina , SARS-CoV-2 , Volume Sistólico , Função Ventricular Esquerda
19.
Orv Hetil ; 151(5): 163-71, 2010 Jan 31.
Artigo em Húngaro | MEDLINE | ID: mdl-20083464

RESUMO

UNLABELLED: Several transcatheter techniques based on radiofrequency energy were elaborated for the treatment of atrial fibrillation through the last decade. Recently, similar success rates with a better safety profile concerning life threatening complications were reported with the novel methode of cryoballon isolation of the pulmonary veins. This paper summarizes our initial experience with cryoballon ablation after the first 55 patients. METHOD: [corrected] Symptomatic patients refractory to aniarrhythmic medication mostly with paroxysmal atrial fibrillation without significant structural heart disease were enrolled. Cannulation and isolation of all pulmonary veins were attempted using a 28 mm double-wall cryoballon inflated at the ostium of the vein and abolishing eletrical activity of atrial tissue around its perimeter by freezing to -70 C. Intravenous heparin during and oral anticoagulant after the procedure was administered. Conventional ECGs, Holter ECGs and transtelephonic ECG recordings were used through 6 months follow-up for rhythm monitoring. RESULTS: In 55 patients enrolled (18 female; age: 56 + or - 33,64 years) 165 out ot 192 (86%) pulmonary veins were successfully isolated. All pulmonary veins were isolated in 37 patients (67%). Procedure time was 155.67 + or - 100.66 min, while fluoroscopy time was 34.04 + or - 31.89 min. In 34 patients with 6 months follow-up 24 (70%) either remained free of arrhythmia (17 patients) or had a significant decrease in arrhythmia burden (7 patients). CONCLUSION: Based on our initial experience, cryoballon isolation of pulmonary veins appears to be a more simple procedure with similar efficacy to radiofrequency ablation in the treatment of atrial fibrillation.


Assuntos
Fibrilação Atrial/terapia , Cateterismo , Criocirurgia , Veias Pulmonares/cirurgia , Adulto , Idoso , Idoso de 80 Anos ou mais , Fibrilação Atrial/fisiopatologia , Fibrilação Atrial/cirurgia , Cateterismo/métodos , Criocirurgia/métodos , Eletrocardiografia , Eletrocardiografia Ambulatorial , Feminino , Fluoroscopia , Humanos , Masculino , Pessoa de Meia-Idade , Flebografia , Veias Pulmonares/diagnóstico por imagem , Resultado do Tratamento
20.
Orv Hetil ; 151(7): 243-9, 2010 Feb 14.
Artigo em Húngaro | MEDLINE | ID: mdl-20133243

RESUMO

Fabry disease is a rare, X-linked lysosomal storage disorder that leads to accumulation of globotriaosylceramide in different tissues of the body. The disease is progressive, first symptoms usually present in childhood. Consequencies of the diseases are disability and premature death. The disease in females could be as severe as in males although women may also be asymptomatic. The possibility of enzyme replacement therapy has made it necessary to elaborate a comprehensive guideline for the diagnosis and treatment follow-up. The guideline was established by a Hungarian multi-disciplinary working group, consisting of physicians who are involved in health care of Fabry patients. Previous clinical studies, published materials, and recently established international treatment guidelines were reviewed by the group.


Assuntos
Doença de Fabry/diagnóstico , alfa-Galactosidase/administração & dosagem , alfa-Galactosidase/metabolismo , Sistema Cardiovascular/metabolismo , Sistema Cardiovascular/patologia , Cromatografia Líquida de Alta Pressão , Diagnóstico Diferencial , Doença de Fabry/complicações , Doença de Fabry/tratamento farmacológico , Doença de Fabry/enzimologia , Doença de Fabry/genética , Feminino , Trato Gastrointestinal , Humanos , Rim/metabolismo , Rim/patologia , Pulmão/fisiopatologia , Masculino , Espectrometria de Massas , Sistema Nervoso/metabolismo , Sistema Nervoso/patologia , Pele/metabolismo , Pele/patologia , Triexosilceramidas/sangue , Triexosilceramidas/metabolismo , Visão Ocular , alfa-Galactosidase/sangue , alfa-Galactosidase/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA